Clinical Trials Directory

Trials / Completed

CompletedNCT03030170

REinforcement of the Pancreas in distaL pAncreatectomY (REPLAY)

Does the Strengthening of the Pancreas in Distal Pancreatectomy Using Endo GIA Reload Reinforced Reduce the Occurrence of Pancreatic Fistula? Multicenter Randomized Prospective Open Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
207 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Despite an improvement regarding morbidity and mortality since 30 years, especially in expert centers, pancreatic surgery remains currently associated to a significant postoperative morbidity reaching more than 60%. Regarding distal pancreatectomy (DP), the main complication following surgery is the occurrence of postoperative pancreatic fistula (PF) which may be able to lead an increased risk of bleeding, gastroparesis and finally a longer hospital stays. The main risk factors associated to the occurrence of pancreatic fistula are represented by the texture of the pancreatic parenchyma (soft pancreas) and the caliber of the main pancreatic duct (\<3mm). Looking for new means of reducing the occurrence of pancreatic fistula is a priority in pancreatic surgery and a genuine public health issue. Currently, no formal recommendations concerning the optimal technical for closure of the distal stump in DP are available. In fact, manual closing by elective suturing or stapling of the main pancreatic duct give similar results. The use of a reinforcing stapling potentially represents a simple way to decrease the occurrence of pancreatic fistula and requires evaluation by a prospective randomized study.

Conditions

Interventions

TypeNameDescription
DEVICEENDO GIA X-tra Thick reload with Tri Staple TechnologySuture of the pancreas by normal stapling
DEVICEENDO GIA Articulating Reinforced Reload with Tri-Staple TechnologySuture of the pancreas by reinforced stapling

Timeline

Start date
2017-06-28
Primary completion
2020-12-14
Completion
2021-07-30
First posted
2017-01-24
Last updated
2023-08-09

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03030170. Inclusion in this directory is not an endorsement.